🕵️ Indivior Pharmaceuticals, Inc. ($INDV)
SEC insider & ownership activity, last 12 months · CIK 1625297 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. BlackRock, Inc. added 6.8% → 14.3%. No red-flag 8-Ks in the window.
Insider flow
7 buyers, value withheld pending verification (10 lots) · 2 sellers, $2.8M (3 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Heidbreder Christian | 0 | – | 2 | $1.5M | Jul 10, 2026 |
| Preblick Ryan | 0 | – | 1 | $1.4M | Jun 8, 2026 |
| Woodrow D. Anderson | 2 | $108K | 0 | – | Aug 27, 2026 |
| Stuart A. Kingsley | 1 | $30K | 0 | – | Mar 6, 2026 |
| Ryan Barbara | 3 | value withheld pending verification | 0 | – | Mar 13, 2026 |
| Daniel A. Ninivaggi | 1 | value withheld pending verification | 0 | – | Jan 5, 2026 |
| David E. Wheadon | 1 | value withheld pending verification | 0 | – | Jan 5, 2026 |
| Humphreys Keith | 1 | value withheld pending verification | 0 | – | Jan 5, 2026 |
| Stejbach Mark | 1 | value withheld pending verification | 0 | – | Jan 5, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14.3% | 13G | Jan 8, 2026 | filing ↗ | |
| Vanguard Portfolio Management | 6.5% | 13G | Apr 28, 2026 | filing ↗ | |
| Oaktree Capital Group Holdings GP, LLC | 5.7% | 13D | Dec 24, 2025 | filing ↗ | |
| Vanguard Capital Management | 5.3% | 13G | Apr 27, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Heidbreder Christian | $765K | Jul 10, 2026 | filing ↗ |
| Heidbreder Christian | $707K | Jun 11, 2026 | filing ↗ |
| Preblick Ryan | $1.4M | Jun 8, 2026 | filing ↗ |
| Cynthia C. Cetani | $3.7M | Nov 7, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Agreement terminated (1.02) | Sep 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 3, 2026 | filing ↗ |
| Earnings (2.02) | Aug 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 3, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 1, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 13, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 4, 2026 | filing ↗ |
| Other events (8.01) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |
| Earnings (2.02) | Apr 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 17, 2026 | filing ↗ |
| Agreement terminated (1.02) | Mar 17, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 17, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 17, 2026 | filing ↗ |
| Other events (8.01) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Other events (8.01) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |